NON-SMALL CELL LUNG CANCER STAGE I
Clinical trials for NON-SMALL CELL LUNG CANCER STAGE I explained in plain language.
Never miss a new study
Get alerted when new NON-SMALL CELL LUNG CANCER STAGE I trials appear
Sign up with your email to follow new studies for NON-SMALL CELL LUNG CANCER STAGE I, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Blood test spots hidden cancer, guides new treatment to stop it returning
Disease control Recruiting nowThis study is for people with early-stage non-small cell lung cancer who have finished their standard treatment. It uses a special blood test to look for tiny leftover cancer signals. If the test is positive, participants receive a drug called durvalumab to try to clear these sig…
Matched conditions: NON-SMALL CELL LUNG CANCER STAGE I
Phase: PHASE2 • Sponsor: Stanford University • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
New drug aims to shield lungs during cancer radiation
Disease control Recruiting nowThis study is testing whether a drug called BIO 300 can help protect the lungs of patients who have both early-stage lung cancer and a separate lung scarring disease (interstitial lung disease) when they receive radiation therapy. The main goal is to see if BIO 300 can prevent se…
Matched conditions: NON-SMALL CELL LUNG CANCER STAGE I
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC